2017-03-24,Immunomedics, Mylan Lead Biotech Movers
2017-03-22,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 18% Using Options
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-02-28,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2016 Financial Results
2017-02-03,Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares
2017-01-31,Rigel Announces Pricing Of Public Offering Of Common Stock
2017-01-30,Rigel Announces Proposed Public Offering Of Common Stock
2017-01-30,Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen
2017-01-16,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2017-01-05,Rigel Provides Business Updates And Preliminary Data In IgA Nephropathy
2016-12-20,First Week Of RIGL February 2017 Options Trading
2016-11-22,First Week of January 2017 Options Trading For Rigel Pharmaceuticals (RIGL)
2016-11-10,Rigel To Present At Jefferies 2016 London Healthcare Conference
2016-10-28,Rigel Announces Conference Call And Webcast To Report Third Quarter 2016 Financial Results
2016-10-10,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-10-07,Rigel Expands Leadership Team In Research And Business Development
2016-09-27,Short Interest Moves 115.3% Higher For RIGL
2016-09-20,Interesting RIGL Put And Call Options For November 18th
2016-09-15,Rigel Restructures To Focus On Fostamatinib Commercialization
2016-08-30,Rigel Pharma (RIGL) Stock Jumps on Study Results, Piper Jaffray Ups Price Target
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug
2016-08-30,Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP
2016-08-29,Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016
2016-08-08,Rigel Pharmaceuticals (RIGL) Weak On High Volume Today
2016-07-26,Rigel Announces Conference Call And Webcast To Report Second Quarter 2016 Financial Results
2016-06-02,Rigel To Present At Jefferies 2016 Healthcare Conference
2016-05-05,Rigel To Present At Upcoming American Association Of Immunologists (AAI) Annual Meeting
2016-04-26,Rigel Announces Conference Call And Webcast To Report First Quarter 2016 Financial Results
2016-04-12,Rigel Announces Presentations At Upcoming American Association Of Cancer Research (AACR) Conference
2016-04-01,Rigel Completes Enrollment Of FIT Phase 3 Program For Fostamatinib In ITP
2016-03-08,Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer
2016-03-01,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2015 Financial Results
2016-02-29,Rigel To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-25,Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia
2016-01-28,Rigel Completes Enrollment Of First Phase 3 Study Of Fostamatinib In ITP (FIT)
2016-01-07,Rigel Reviews Recent Progress And Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference In San Francisco
2015-10-27,Rigel Announces Conference Call And Webcast To Report Third Quarter 2015 Financial Results
2015-09-09,Rigel And Aclaris Therapeutics International Sign License Agreement For JAK Inhibitors To Treat Skin Disorders
2015-09-08,Rigel Granted Orphan Drug Designation For Fostamatinib In ITP
2015-07-28,Rigel Announces Conference Call And Webcast To Report Second Quarter 2015 Financial Results
2015-06-30,Rigel Welcomes Keith A. Katkin To Board Of Directors
2015-06-26,Short Interest In Rigel Pharmaceuticals Makes 14.2% Move
2015-05-28,Rigel To Present At Jefferies 2015 Global Healthcare Conference
2015-05-14,Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today
2015-04-30,Rigel Announces Conference Call And Webcast To Report First Quarter 2015 Financial Results And Pipeline Update
2015-03-09,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized Using Options
2015-02-23,Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies
2015-02-23,Rigel And Bristol-Myers Squibb Announce Research And Development Collaboration For TGF Beta Receptor Kinase Inhibitors For Use In Immuno-Oncology Related Indications
2015-01-13,Short Interest Moves 40.6% Lower For RIGL
2015-01-08,Rigel To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-11-24,Rigel Announces Executive Management Changes
2014-08-13,Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today
2014-08-13,R348 Did Not Meet Endpoints In Phase 2 Dry Eye Study
2014-08-06,First Week of RIGL March 2015 Options Trading
2014-07-16,Rigel Initiates Phase 3 Studies of Fostamatinib in ITP
2014-05-29,Rigel To Present At Jefferies 2014 Global Healthcare Conference
2014-05-21,First Week of July 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-04-30,Rigel Announces Webcast Of Investor Day On May 6, 2014
2014-03-06,Rigel Announces Publication Of R118 AMPK Activator Research
2014-02-27,Rigel Announces Participation At Two Investor Conferences
2014-02-26,First Week of April 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-02-06,Rigel Announces Participation At Two Investor Conferences
2014-01-23,First Week Of September 20th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-01-10,Rigel Will Present Clinical Product Portfolio Update At J.P. Morgan Healthcare Conference
2013-12-27,First Week of February 2014 Options Trading For Rigel Pharmaceuticals (RIGL)
2013-12-05,Rigel To Present At Oppenheimer Healthcare Conference
2013-10-24,Rigel Provides Pipeline Update
2013-09-27,First Week Of November 16th Options Trading For Rigel Pharmaceuticals (RIGL)
2013-09-06,Rigel To Present At Stifel Healthcare Conference
2013-09-05,Rigel To Focus On ITP, DLE And Dry Eye
2013-08-26,Rigel's R343 Did Not Meet Primary Endpoint In Asthma Study
2013-08-07,3 Stocks Under $10 Moving Higher
2013-06-11,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized
2013-05-22,Rigel's R348 To Initiate Phase 2 Clinical Trial In Dry Eye
2013-05-03,Rigel Pharmaceuticals Becomes Oversold (RIGL)
2013-04-18,5 Health Care Stocks Under $10 Ready to Rip Higher
2013-04-12,5 Stocks Poised for Breakouts
2013-04-05,Frail Jobs Gains Give Markets Jitters
2013-04-05,Astra, Rigel Arthritis Pill Posts Mixed Trial Results
2013-03-15,3 Stocks Under $10 Making Big Moves
2013-02-28,Rigel Announces Participation At Two Investor Conferences
2013-02-07,Rigel To Present At BIO CEO & Investor Conference
2013-01-03,Rigel To Focus On Extensive Clinical Pipeline At Upcoming J.P. Morgan Presentation
2012-12-13,AstraZeneca Announces Top-Line Results Of OSKIRA-4 Phase IIb Study Of Fostamatinib As A Monotherapy For Rheumatoid Arthritis
2012-11-08,Rigel To Present At Jefferies 2012 Global Healthcare Conference In London
2012-10-03,Rigel Announces Pricing Of Public Offering Of Common Stock
2012-10-02,Rigel Announces Proposed Public Offering Of Common Stock
2012-09-25,Stocks Under $10: Blossoming Biotech Play
2012-09-17,Rigel To Present At UBS Global Life Sciences Conference
2012-09-05,Rigel Initiates Phase 2 Clinical Studies With R343 For Asthma And R333 For Discoid Lupus
2012-06-19,AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
2012-05-31,Rigel Announces Participation At Two Investor Conferences
2012-05-16,Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim At Acute And Chronic Lung Disease
2012-05-04,The Next Big Thing in Biotech: Pfizer
2012-02-23,Rigel Announces Participation At Two Investor Conferences
2012-01-05,Rigel Announces Initiation Of Clinical Trials In Two Immunology Programs
2011-12-07,Rigel To Present At Oppenheimer Annual Healthcare Conference
2011-11-03,Rigel To Participate At Two Upcoming Investor Conferences
2011-10-06,Rigel To Webcast Investor Day On October 13, 2011
2011-10-03,Biotech Calendar: Key Dates for October
2011-09-06,Vertex Arthritis Pill Shines in Mid-Stage Study
2011-06-16,Rigel To Present At Wells Fargo Securities Healthcare Conference
2011-06-03,Rigel To Present At Jefferies Global Healthcare Conference
2011-05-26,Rigel Stock Falls On Unusually High Volume (RIGL)
2011-05-26,Rigel Announces Pricing Of Public Offering Of Common Stock
2011-05-25,Rigel Announces Proposed Public Offering Of Common Stock
2011-05-06,Rigel Assumes Development Responsibility For Inhaled Asthma Therapy
2011-05-05,Rigel To Present At Bank Of America Merrill Lynch Health Care Conference
2011-03-07,Rigel Pharmaceuticals Inc. Stock Downgraded (RIGL)
2010-02-16,Brocade, Rigel, ARM: Early Volume Plays
2010-02-16,Rigel May Get $1.245B in Drug License Pact
2010-01-05,Analysts Name Top Biotech Stocks for 2010: BioBuzz
2009-11-23,Rigel Shares Rise On RBC Analyst Upgrade
2009-11-10,Bristol Licenses Arthritis Drug: BioBuzz
2009-11-03,Rigel 3Q Loss Narrows On Lower Costs
2009-10-20,Galleon's Biotech Stock Holdings: BioBuzz
2009-09-17,Psst... These Drug Firms Are Getting Bought: BioBuzz
2009-07-09,Rigel's R788 Drug Improves RA Symptoms
2009-06-15,New RA Data Could Be Magic Pill for Rigel
2009-06-10,Biotech Calendar: Key Clinical Trial Dates
2009-06-09,Movers Roundup: Rigel Pharma, Mueller Water
2009-06-09,Analyst: Rigel Arthritis Drug Poised To Compete
2009-02-03,Rigel Falls on Drug-Deal Delays, Layoffs
2008-12-08,Single Drugmakers Seek Rich Partners
2008-10-28,Health Winners & Losers: Genzyme
2008-10-28,Rigel Shares Tank on Arthritis Data (Update)
2008-10-27,Incyte's Rheumatoid Arthritis Pill Promising
2008-08-27,Health Winners & Losers: Cell Genesys
2008-08-15,Biotech-Stock Mailbag: Genentech
2008-03-17,Feuerstein's Biotech-Stock Mailbag: Navigating the Sector Swoon
2008-01-31,Focus on Jobs Report
2007-12-14,Friday's Health Winners & Losers
2007-12-13,Thursday's Health Winners & Losers
2007-12-13,Fed Fallout Keeps Bull Contained
2007-12-13,Rigel Pharma Surges on Drug Data
2007-12-06,Thursday's Health Winners & Losers
2007-05-03,Stock Sale Hits Rigel
2007-04-30,Monday's Health Winners and Losers
2006-12-12,Tuesday's Health Winners & Losers
2006-05-17,Today's Health Winners and Losers
2005-12-01,Health Stocks in Motion
2005-12-01,Rigel Shares Get Crushed
2005-12-01,Stocks in Motion: World Wrestling
2005-07-15,Health Stocks in Motion
2004-11-05,Health Stocks in Motion
2004-08-08,Weekend Reading: Jobs Data Surprise Becomes Fed Fear
2004-08-02,Health Stocks in Motion
2001-05-23,Don't Lose Sleep Over Specialty Laboratories
2001-05-16,Rigel Expiration Could Signal a Yard Sale
2017-03-24,Immunomedics, Mylan Lead Biotech Movers
2017-03-22,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 18% Using Options
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-02-28,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2016 Financial Results
2017-02-03,Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares
2017-01-31,Rigel Announces Pricing Of Public Offering Of Common Stock
2017-01-30,Rigel Announces Proposed Public Offering Of Common Stock
2017-01-30,Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen
2017-01-16,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2017-01-05,Rigel Provides Business Updates And Preliminary Data In IgA Nephropathy
2016-12-20,First Week Of RIGL February 2017 Options Trading
2016-11-22,First Week of January 2017 Options Trading For Rigel Pharmaceuticals (RIGL)
2016-11-10,Rigel To Present At Jefferies 2016 London Healthcare Conference
2016-10-28,Rigel Announces Conference Call And Webcast To Report Third Quarter 2016 Financial Results
2016-10-10,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-10-07,Rigel Expands Leadership Team In Research And Business Development
2016-09-27,Short Interest Moves 115.3% Higher For RIGL
2016-09-20,Interesting RIGL Put And Call Options For November 18th
2016-09-15,Rigel Restructures To Focus On Fostamatinib Commercialization
2016-08-30,Rigel Pharma (RIGL) Stock Jumps on Study Results, Piper Jaffray Ups Price Target
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug
2016-08-30,Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP
2016-08-29,Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016
2016-08-08,Rigel Pharmaceuticals (RIGL) Weak On High Volume Today
2016-07-26,Rigel Announces Conference Call And Webcast To Report Second Quarter 2016 Financial Results
2016-06-02,Rigel To Present At Jefferies 2016 Healthcare Conference
2016-05-05,Rigel To Present At Upcoming American Association Of Immunologists (AAI) Annual Meeting
2016-04-26,Rigel Announces Conference Call And Webcast To Report First Quarter 2016 Financial Results
2016-04-12,Rigel Announces Presentations At Upcoming American Association Of Cancer Research (AACR) Conference
2016-04-01,Rigel Completes Enrollment Of FIT Phase 3 Program For Fostamatinib In ITP
2016-03-08,Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer
2016-03-01,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2015 Financial Results
2016-02-29,Rigel To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-25,Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia
2016-01-28,Rigel Completes Enrollment Of First Phase 3 Study Of Fostamatinib In ITP (FIT)
2016-01-07,Rigel Reviews Recent Progress And Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference In San Francisco
2015-10-27,Rigel Announces Conference Call And Webcast To Report Third Quarter 2015 Financial Results
2015-09-09,Rigel And Aclaris Therapeutics International Sign License Agreement For JAK Inhibitors To Treat Skin Disorders
2015-09-08,Rigel Granted Orphan Drug Designation For Fostamatinib In ITP
2015-07-28,Rigel Announces Conference Call And Webcast To Report Second Quarter 2015 Financial Results
2015-06-30,Rigel Welcomes Keith A. Katkin To Board Of Directors
2015-06-26,Short Interest In Rigel Pharmaceuticals Makes 14.2% Move
2015-05-28,Rigel To Present At Jefferies 2015 Global Healthcare Conference
2015-05-14,Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today
2015-04-30,Rigel Announces Conference Call And Webcast To Report First Quarter 2015 Financial Results And Pipeline Update
2015-03-09,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized Using Options
2015-02-23,Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies
2015-02-23,Rigel And Bristol-Myers Squibb Announce Research And Development Collaboration For TGF Beta Receptor Kinase Inhibitors For Use In Immuno-Oncology Related Indications
2015-01-13,Short Interest Moves 40.6% Lower For RIGL
2015-01-08,Rigel To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-11-24,Rigel Announces Executive Management Changes
2014-08-13,Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today
2014-08-13,R348 Did Not Meet Endpoints In Phase 2 Dry Eye Study
2014-08-06,First Week of RIGL March 2015 Options Trading
2014-07-16,Rigel Initiates Phase 3 Studies of Fostamatinib in ITP
2014-05-29,Rigel To Present At Jefferies 2014 Global Healthcare Conference
2014-05-21,First Week of July 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-04-30,Rigel Announces Webcast Of Investor Day On May 6, 2014
2014-03-06,Rigel Announces Publication Of R118 AMPK Activator Research
2014-02-27,Rigel Announces Participation At Two Investor Conferences
2014-02-26,First Week of April 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-02-06,Rigel Announces Participation At Two Investor Conferences
2014-01-23,First Week Of September 20th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-01-10,Rigel Will Present Clinical Product Portfolio Update At J.P. Morgan Healthcare Conference
2013-12-27,First Week of February 2014 Options Trading For Rigel Pharmaceuticals (RIGL)
2013-12-05,Rigel To Present At Oppenheimer Healthcare Conference
2013-10-24,Rigel Provides Pipeline Update
2013-09-27,First Week Of November 16th Options Trading For Rigel Pharmaceuticals (RIGL)
2013-09-06,Rigel To Present At Stifel Healthcare Conference
2013-09-05,Rigel To Focus On ITP, DLE And Dry Eye
2013-08-26,Rigel's R343 Did Not Meet Primary Endpoint In Asthma Study
2013-08-07,3 Stocks Under $10 Moving Higher
2013-06-11,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized
2013-05-22,Rigel's R348 To Initiate Phase 2 Clinical Trial In Dry Eye
2013-05-03,Rigel Pharmaceuticals Becomes Oversold (RIGL)
2013-04-18,5 Health Care Stocks Under $10 Ready to Rip Higher
2013-04-12,5 Stocks Poised for Breakouts
2013-04-05,Frail Jobs Gains Give Markets Jitters
2013-04-05,Astra, Rigel Arthritis Pill Posts Mixed Trial Results
2013-03-15,3 Stocks Under $10 Making Big Moves
2013-02-28,Rigel Announces Participation At Two Investor Conferences
2013-02-07,Rigel To Present At BIO CEO & Investor Conference
2013-01-03,Rigel To Focus On Extensive Clinical Pipeline At Upcoming J.P. Morgan Presentation
2012-12-13,AstraZeneca Announces Top-Line Results Of OSKIRA-4 Phase IIb Study Of Fostamatinib As A Monotherapy For Rheumatoid Arthritis
2012-11-08,Rigel To Present At Jefferies 2012 Global Healthcare Conference In London
2012-10-03,Rigel Announces Pricing Of Public Offering Of Common Stock
2012-10-02,Rigel Announces Proposed Public Offering Of Common Stock
2012-09-25,Stocks Under $10: Blossoming Biotech Play
2012-09-17,Rigel To Present At UBS Global Life Sciences Conference
2012-09-05,Rigel Initiates Phase 2 Clinical Studies With R343 For Asthma And R333 For Discoid Lupus
2012-06-19,AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
2012-05-31,Rigel Announces Participation At Two Investor Conferences
2012-05-16,Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim At Acute And Chronic Lung Disease
2012-05-04,The Next Big Thing in Biotech: Pfizer
2012-02-23,Rigel Announces Participation At Two Investor Conferences
2012-01-05,Rigel Announces Initiation Of Clinical Trials In Two Immunology Programs
2011-12-07,Rigel To Present At Oppenheimer Annual Healthcare Conference
2011-11-03,Rigel To Participate At Two Upcoming Investor Conferences
2011-10-06,Rigel To Webcast Investor Day On October 13, 2011
2011-10-03,Biotech Calendar: Key Dates for October
2011-09-06,Vertex Arthritis Pill Shines in Mid-Stage Study
2011-06-16,Rigel To Present At Wells Fargo Securities Healthcare Conference
2011-06-03,Rigel To Present At Jefferies Global Healthcare Conference
2011-05-26,Rigel Stock Falls On Unusually High Volume (RIGL)
2011-05-26,Rigel Announces Pricing Of Public Offering Of Common Stock
2011-05-25,Rigel Announces Proposed Public Offering Of Common Stock
2011-05-06,Rigel Assumes Development Responsibility For Inhaled Asthma Therapy
2011-05-05,Rigel To Present At Bank Of America Merrill Lynch Health Care Conference
2011-03-07,Rigel Pharmaceuticals Inc. Stock Downgraded (RIGL)
2010-02-16,Brocade, Rigel, ARM: Early Volume Plays
2010-02-16,Rigel May Get $1.245B in Drug License Pact
2010-01-05,Analysts Name Top Biotech Stocks for 2010: BioBuzz
2009-11-23,Rigel Shares Rise On RBC Analyst Upgrade
2009-11-10,Bristol Licenses Arthritis Drug: BioBuzz
2009-11-03,Rigel 3Q Loss Narrows On Lower Costs
2009-10-20,Galleon's Biotech Stock Holdings: BioBuzz
2009-09-17,Psst... These Drug Firms Are Getting Bought: BioBuzz
2009-07-09,Rigel's R788 Drug Improves RA Symptoms
2009-06-15,New RA Data Could Be Magic Pill for Rigel
2009-06-10,Biotech Calendar: Key Clinical Trial Dates
2009-06-09,Movers Roundup: Rigel Pharma, Mueller Water
2009-06-09,Analyst: Rigel Arthritis Drug Poised To Compete
2009-02-03,Rigel Falls on Drug-Deal Delays, Layoffs
2008-12-08,Single Drugmakers Seek Rich Partners
2008-10-28,Health Winners & Losers: Genzyme
2008-10-28,Rigel Shares Tank on Arthritis Data (Update)
2008-10-27,Incyte's Rheumatoid Arthritis Pill Promising
2008-08-27,Health Winners & Losers: Cell Genesys
2008-08-15,Biotech-Stock Mailbag: Genentech
2008-03-17,Feuerstein's Biotech-Stock Mailbag: Navigating the Sector Swoon
2008-01-31,Focus on Jobs Report
2007-12-14,Friday's Health Winners & Losers
2007-12-13,Thursday's Health Winners & Losers
2007-12-13,Fed Fallout Keeps Bull Contained
2007-12-13,Rigel Pharma Surges on Drug Data
2007-12-06,Thursday's Health Winners & Losers
2007-05-03,Stock Sale Hits Rigel
2007-04-30,Monday's Health Winners and Losers
2006-12-12,Tuesday's Health Winners & Losers
2006-05-17,Today's Health Winners and Losers
2005-12-01,Health Stocks in Motion
2005-12-01,Rigel Shares Get Crushed
2005-12-01,Stocks in Motion: World Wrestling
2005-07-15,Health Stocks in Motion
2004-11-05,Health Stocks in Motion
2004-08-08,Weekend Reading: Jobs Data Surprise Becomes Fed Fear
2004-08-02,Health Stocks in Motion
2001-05-23,Don't Lose Sleep Over Specialty Laboratories
2001-05-16,Rigel Expiration Could Signal a Yard Sale
2017-03-24,Immunomedics, Mylan Lead Biotech Movers
2017-03-22,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 18% Using Options
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-02-28,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2016 Financial Results
2017-02-03,Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares
2017-01-31,Rigel Announces Pricing Of Public Offering Of Common Stock
2017-01-30,Rigel Announces Proposed Public Offering Of Common Stock
2017-01-30,Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen
2017-01-16,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2017-01-05,Rigel Provides Business Updates And Preliminary Data In IgA Nephropathy
2016-12-20,First Week Of RIGL February 2017 Options Trading
2016-11-22,First Week of January 2017 Options Trading For Rigel Pharmaceuticals (RIGL)
2016-11-10,Rigel To Present At Jefferies 2016 London Healthcare Conference
2016-10-28,Rigel Announces Conference Call And Webcast To Report Third Quarter 2016 Financial Results
2016-10-10,Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-10-07,Rigel Expands Leadership Team In Research And Business Development
2016-09-27,Short Interest Moves 115.3% Higher For RIGL
2016-09-20,Interesting RIGL Put And Call Options For November 18th
2016-09-15,Rigel Restructures To Focus On Fostamatinib Commercialization
2016-08-30,Rigel Pharma (RIGL) Stock Jumps on Study Results, Piper Jaffray Ups Price Target
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug
2016-08-30,Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP
2016-08-29,Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016
2016-08-08,Rigel Pharmaceuticals (RIGL) Weak On High Volume Today
2016-07-26,Rigel Announces Conference Call And Webcast To Report Second Quarter 2016 Financial Results
2016-06-02,Rigel To Present At Jefferies 2016 Healthcare Conference
2016-05-05,Rigel To Present At Upcoming American Association Of Immunologists (AAI) Annual Meeting
2016-04-26,Rigel Announces Conference Call And Webcast To Report First Quarter 2016 Financial Results
2016-04-12,Rigel Announces Presentations At Upcoming American Association Of Cancer Research (AACR) Conference
2016-04-01,Rigel Completes Enrollment Of FIT Phase 3 Program For Fostamatinib In ITP
2016-03-08,Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer
2016-03-01,Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2015 Financial Results
2016-02-29,Rigel To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-25,Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia
2016-01-28,Rigel Completes Enrollment Of First Phase 3 Study Of Fostamatinib In ITP (FIT)
2016-01-07,Rigel Reviews Recent Progress And Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference In San Francisco
2015-10-27,Rigel Announces Conference Call And Webcast To Report Third Quarter 2015 Financial Results
2015-09-09,Rigel And Aclaris Therapeutics International Sign License Agreement For JAK Inhibitors To Treat Skin Disorders
2015-09-08,Rigel Granted Orphan Drug Designation For Fostamatinib In ITP
2015-07-28,Rigel Announces Conference Call And Webcast To Report Second Quarter 2015 Financial Results
2015-06-30,Rigel Welcomes Keith A. Katkin To Board Of Directors
2015-06-26,Short Interest In Rigel Pharmaceuticals Makes 14.2% Move
2015-05-28,Rigel To Present At Jefferies 2015 Global Healthcare Conference
2015-05-14,Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today
2015-04-30,Rigel Announces Conference Call And Webcast To Report First Quarter 2015 Financial Results And Pipeline Update
2015-03-09,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized Using Options
2015-02-23,Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies
2015-02-23,Rigel And Bristol-Myers Squibb Announce Research And Development Collaboration For TGF Beta Receptor Kinase Inhibitors For Use In Immuno-Oncology Related Indications
2015-01-13,Short Interest Moves 40.6% Lower For RIGL
2015-01-08,Rigel To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-11-24,Rigel Announces Executive Management Changes
2014-08-13,Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today
2014-08-13,R348 Did Not Meet Endpoints In Phase 2 Dry Eye Study
2014-08-06,First Week of RIGL March 2015 Options Trading
2014-07-16,Rigel Initiates Phase 3 Studies of Fostamatinib in ITP
2014-05-29,Rigel To Present At Jefferies 2014 Global Healthcare Conference
2014-05-21,First Week of July 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-04-30,Rigel Announces Webcast Of Investor Day On May 6, 2014
2014-03-06,Rigel Announces Publication Of R118 AMPK Activator Research
2014-02-27,Rigel Announces Participation At Two Investor Conferences
2014-02-26,First Week of April 19th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-02-06,Rigel Announces Participation At Two Investor Conferences
2014-01-23,First Week Of September 20th Options Trading For Rigel Pharmaceuticals (RIGL)
2014-01-10,Rigel Will Present Clinical Product Portfolio Update At J.P. Morgan Healthcare Conference
2013-12-27,First Week of February 2014 Options Trading For Rigel Pharmaceuticals (RIGL)
2013-12-05,Rigel To Present At Oppenheimer Healthcare Conference
2013-10-24,Rigel Provides Pipeline Update
2013-09-27,First Week Of November 16th Options Trading For Rigel Pharmaceuticals (RIGL)
2013-09-06,Rigel To Present At Stifel Healthcare Conference
2013-09-05,Rigel To Focus On ITP, DLE And Dry Eye
2013-08-26,Rigel's R343 Did Not Meet Primary Endpoint In Asthma Study
2013-08-07,3 Stocks Under $10 Moving Higher
2013-06-11,Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized
2013-05-22,Rigel's R348 To Initiate Phase 2 Clinical Trial In Dry Eye
2013-05-03,Rigel Pharmaceuticals Becomes Oversold (RIGL)
2013-04-18,5 Health Care Stocks Under $10 Ready to Rip Higher
2013-04-12,5 Stocks Poised for Breakouts
2013-04-05,Frail Jobs Gains Give Markets Jitters
2013-04-05,Astra, Rigel Arthritis Pill Posts Mixed Trial Results
2013-03-15,3 Stocks Under $10 Making Big Moves
2013-02-28,Rigel Announces Participation At Two Investor Conferences
2013-02-07,Rigel To Present At BIO CEO & Investor Conference
2013-01-03,Rigel To Focus On Extensive Clinical Pipeline At Upcoming J.P. Morgan Presentation
2012-12-13,AstraZeneca Announces Top-Line Results Of OSKIRA-4 Phase IIb Study Of Fostamatinib As A Monotherapy For Rheumatoid Arthritis
2012-11-08,Rigel To Present At Jefferies 2012 Global Healthcare Conference In London
2012-10-03,Rigel Announces Pricing Of Public Offering Of Common Stock
2012-10-02,Rigel Announces Proposed Public Offering Of Common Stock
2012-09-25,Stocks Under $10: Blossoming Biotech Play
2012-09-17,Rigel To Present At UBS Global Life Sciences Conference
2012-09-05,Rigel Initiates Phase 2 Clinical Studies With R343 For Asthma And R333 For Discoid Lupus
2012-06-19,AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
2012-05-31,Rigel Announces Participation At Two Investor Conferences
2012-05-16,Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim At Acute And Chronic Lung Disease
2012-05-04,The Next Big Thing in Biotech: Pfizer
2012-02-23,Rigel Announces Participation At Two Investor Conferences
2012-01-05,Rigel Announces Initiation Of Clinical Trials In Two Immunology Programs
2011-12-07,Rigel To Present At Oppenheimer Annual Healthcare Conference
2011-11-03,Rigel To Participate At Two Upcoming Investor Conferences
2011-10-06,Rigel To Webcast Investor Day On October 13, 2011
2011-10-03,Biotech Calendar: Key Dates for October
2011-09-06,Vertex Arthritis Pill Shines in Mid-Stage Study
2011-06-16,Rigel To Present At Wells Fargo Securities Healthcare Conference
2011-06-03,Rigel To Present At Jefferies Global Healthcare Conference
2011-05-26,Rigel Stock Falls On Unusually High Volume (RIGL)
2011-05-26,Rigel Announces Pricing Of Public Offering Of Common Stock
2011-05-25,Rigel Announces Proposed Public Offering Of Common Stock
2011-05-06,Rigel Assumes Development Responsibility For Inhaled Asthma Therapy
2011-05-05,Rigel To Present At Bank Of America Merrill Lynch Health Care Conference
2011-03-07,Rigel Pharmaceuticals Inc. Stock Downgraded (RIGL)
2010-02-16,Brocade, Rigel, ARM: Early Volume Plays
2010-02-16,Rigel May Get $1.245B in Drug License Pact
2010-01-05,Analysts Name Top Biotech Stocks for 2010: BioBuzz
2009-11-23,Rigel Shares Rise On RBC Analyst Upgrade
2009-11-10,Bristol Licenses Arthritis Drug: BioBuzz
2009-11-03,Rigel 3Q Loss Narrows On Lower Costs
2009-10-20,Galleon's Biotech Stock Holdings: BioBuzz
2009-09-17,Psst... These Drug Firms Are Getting Bought: BioBuzz
2009-07-09,Rigel's R788 Drug Improves RA Symptoms
2009-06-15,New RA Data Could Be Magic Pill for Rigel
2009-06-10,Biotech Calendar: Key Clinical Trial Dates
2009-06-09,Movers Roundup: Rigel Pharma, Mueller Water
2009-06-09,Analyst: Rigel Arthritis Drug Poised To Compete
2009-02-03,Rigel Falls on Drug-Deal Delays, Layoffs
2008-12-08,Single Drugmakers Seek Rich Partners
2008-10-28,Health Winners & Losers: Genzyme
2008-10-28,Rigel Shares Tank on Arthritis Data (Update)
2008-10-27,Incyte's Rheumatoid Arthritis Pill Promising
2008-08-27,Health Winners & Losers: Cell Genesys
2008-08-15,Biotech-Stock Mailbag: Genentech
2008-03-17,Feuerstein's Biotech-Stock Mailbag: Navigating the Sector Swoon
2008-01-31,Focus on Jobs Report
2007-12-14,Friday's Health Winners & Losers
2007-12-13,Thursday's Health Winners & Losers
2007-12-13,Fed Fallout Keeps Bull Contained
2007-12-13,Rigel Pharma Surges on Drug Data
2007-12-06,Thursday's Health Winners & Losers
2007-05-03,Stock Sale Hits Rigel
2007-04-30,Monday's Health Winners and Losers
2006-12-12,Tuesday's Health Winners & Losers
2006-05-17,Today's Health Winners and Losers
2005-12-01,Health Stocks in Motion
2005-12-01,Rigel Shares Get Crushed
2005-12-01,Stocks in Motion: World Wrestling
2005-07-15,Health Stocks in Motion
2004-11-05,Health Stocks in Motion
2004-08-08,Weekend Reading: Jobs Data Surprise Becomes Fed Fear
2004-08-02,Health Stocks in Motion
2001-05-23,Don't Lose Sleep Over Specialty Laboratories
2001-05-16,Rigel Expiration Could Signal a Yard Sale
